甘酸补充:一种利用和清除的机械模型
1Faculty of Health Sciences, University of Pecs, Pecs, Hungary.
Journal of dietary supplements
|December 24, 2025
概括
甘酸 (GAA) 补充剂可以增强肌酸的产生,但其代谢途径需要一个更清晰的模型. 这项研究模拟了GAA处理,揭示了优化其在营养和治疗中的使用的见解.
科学领域:
- 代谢生物化学 代谢生物化学
- 营养科学 营养科学
- 药理动力学 药理动力学
背景情况:
- 甘酸 (GAA) 是一种具有治疗潜力的肌酸前体.
- 目前缺乏外源GAA的详细代谢模型.
- 了解GAA处理对于优化其营养和治疗应用至关重要.
研究的目的:
- 提出一个集成的代谢模型,用于人体中使用瓜尼迪诺酸 (GAA).
- 综合GAA酶转化,细胞运输和辅助代谢途径的动态证据.
- 为优化GAA补充策略提供一个机制框架.
主要方法:
- 为瓜尼迪诺酸 (GAA) 开发一个综合代谢模型.
- 对瓜尼迪诺酸N-甲基转移酶 (GAMT) 和肌酸运输体 (SLC6A8) 的动态数据的合成.
- 对口服剂量 (1-4 g/天) 的理论GAA流量分布的估计.
主要成果:
- 该模型表明,在低GAA摄入量下,瓜尼迪诺酸N-甲基转移酶 (GAMT) 接近和.
- 由于肌酸竞争,肌酸载体 (SLC6A8) 容量未得到充分利用.
- 对GAA的二次代谢途径不那么重要,但在特定条件下很重要.
结论:
- 拟议的模型为战略性guanidinoacetic acid (GAA) 补充提供了一个机制基础.
- 确定增强肌酸补充和支持线粒体功能的机会.
- 强调需要对临床应用的关键模型参数进行体内验证.
相关概念视频
Clearance Models: Compartment Models
285
Clearance measures drug elimination from the central compartment, including plasma and highly perfused organs like kidneys and liver. Its calculation varies depending on pharmacokinetic models and administration routes. The one-compartment model, for instance, portrays the pharmacokinetics of polar drugs such as aminoglycoside antibiotics administered intravenously and readily excreted in urine. In this case, clearance is influenced by the terminal rate constant (λz) and the total volume...
285
Clearance Models: Physiological Models
266
Drug clearance is a critical pharmacokinetic process involving the irreversible removal of drugs from the body through various organs over a specified time period. Physiological models are indispensable in determining organ-specific clearance, defined by the proportion of the drug eliminated per unit of time from the organ's blood volume.
The organ's clearance rate depends on the blood flow to the organ and the extraction ratio (E). The extraction ratio describes the organ's...
The organ's clearance rate depends on the blood flow to the organ and the extraction ratio (E). The extraction ratio describes the organ's...
266
Clearance Models: Noncompartmental Models
228
Clearance is a pharmacokinetic parameter traditionally defined by compartment models, signifying the rate at which a drug is expelled from the body. However, a noncompartmental model offers an alternative method for assessing clearance, primarily employing empirical data obtained after administering a single drug dose.
The noncompartmental approach capitalizes on extensive sampling data, correlating the volume of distribution to systemic exposure and the administered dosage. This method enables...
The noncompartmental approach capitalizes on extensive sampling data, correlating the volume of distribution to systemic exposure and the administered dosage. This method enables...
228
One-Compartment Open Model for IV Bolus Administration: Estimation of Clearance
320
Clearance is a key pharmacokinetic parameter that quantifies the volume of body fluid from which a drug is entirely removed within a specific time frame. It is crucial in assessing how a drug is eliminated from the body and has critical clinical applications.
In the one-compartment open model for intravenous (IV) bolus administration, clearance is estimated by dividing the elimination rate by the plasma drug concentration. This equation leverages the elimination rate constant and the apparent...
In the one-compartment open model for intravenous (IV) bolus administration, clearance is estimated by dividing the elimination rate by the plasma drug concentration. This equation leverages the elimination rate constant and the apparent...
320
Drug Elimination: The Concept of Clearance
3.7K
Drug elimination refers to removing drugs from the body, either through urine by the kidneys or through bile by the liver. Drug clearance is a pharmacokinetic parameter that measures the efficiency of drug removal from the bloodstream within a specific time frame. It is calculated as the rate at which a drug is eliminated from plasma divided by the plasma concentration of the drug.
Drug clearance is not limited to renal excretion but encompasses all organs involved in drug elimination,...
Drug clearance is not limited to renal excretion but encompasses all organs involved in drug elimination,...
3.7K
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
243
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
A recent model describes pravastatin's hepatobiliary excretion,...
243


